(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
|
(b)(4).Visual inspection was performed on the returned device.The tip detachment was confirmed.Additionally, the stent was partially deployed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history revealed no other incidents reported from this lot.The investigation determined that the reported difficulties were likely due to case circumstances.Based on the analysis of the returned device, there was blood throughout the entire delivery system consistent with the device being advanced into the anatomy or at minimum, into the introducer sheath.Although it was reported that the tip separation was noted after the device was unpacked, the partial deployment of the stent suggests that the thumbslide may have been slightly advanced during or after advancement into the anatomy.Additionally, with the stent partially deployed from the distal sheath, the tip separation likely occurred when the delivery system was retracted into the reduced clearance of the introducer sheath with the partially deployed stent.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
The returned device analysis identified that the supera self-expanding stent system (sess) was returned with blood in and on the sheath indicating that the device had been advanced into the anatomy or at minimum, into the introducer sheath.Additionally, the distal end of the stent was partially deployed.Follow-up with the account stated that the device was not used in the patient and the tip separation occurred outside the patient anatomy.No additional information was provided.
|